Latest News

June 19, 2019
June 19, 2019

ArTara Therapeutics Announces Initiation of New Immunology Pipeline Program with TARA-002, a Toll-Like Receptor 4 Agonist, Targeting Rare Lymphatic Malformations

Do you like it?0
Read more
February 4, 2019
February 4, 2019

ArTara Therapeutics Announces Additions to Leadership Team and Board of Directors

Do you like it?0
Read more
December 18, 2018
December 18, 2018

ArTara Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on Choline Chloride for Injection for Intestinal Failure Associated Liver Disease (IFALD)

Do you like it?0
Read more